Skip to main content
Clinical Trials/CTRI/2024/08/071922
CTRI/2024/08/071922Not yet recruitingPhase 3

A Clinical Study OF Neuroten DM Kalpita Yoga In The Management Of Madhumehjanya UpdravaPeripheral Diabetic Neuropathy - nil

Post Graduate Institute Of Ayurved Jodhpur,Rajastan0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1 Patients having cardinal symptoms of Madhumeha Upadrava like Daha, Harsha, Suptata will
  • be selected
  • 2 Diagnosed cases of Diabetic Neuropathy will be included
  • 3 Mild to moderate Neuropathy patients having Toronto score between 6 to 11 will be included
  • 4 Both fresh and treated cases will be included in the study
  • 5 On-going oral hypoglycaemic agents will be continued during the study
  • 6 No other neuropathy-managing drugs are allowed during the study period
  • 7 Patients aged between 30 to 70 years will be included of both sexes
  • 8 Patients who are willing to sign written consent will be included
  • 9 Patient should be capable of obeying Pathya–apathya

Exclusion Criteria

  • 1 IDDM (Type 1 DM) will be excluded from study
  • 2 Patient with any other serious condition or disease which impact nerves except Diabetic Peripheral Neuropathy will be excluded
  • 3 Pregnant and lactating women will be excluded
  • 4 Patients having any other associated clinical condition like Dementia, Parkinson, or Stroke which influence peripheral nerve function will be excluded
  • 5 Patient having ulceration/infection of feet
  • 6 Medical/Surgical condition limiting functional mobility
  • 7 Non-ambulatory patients
  • 8 who are not willing to participate / consent

Investigators

Sponsor
Post Graduate Institute Of Ayurved Jodhpur,Rajastan

Similar Trials